ImprimisRX Provides 5 of the Top Categories of Ophthalmic Compound Formulations on the Market Today


ImprimisRx formulates the compounded medications American ophthalmologists and optometrists most often prescribe. High-quality formulations by ImprimisRx meet all applicable standards of the U.S. Pharmacopeia (USP) and FDA guidelines.

The ophthalmic portfolio of ImprimisRx includes medications in all five of the top categories of compounded ophthalmic formulations ophthalmologists and optometrists use every day.

ImprimisRx helps ophthalmologists go IV-free

MKO Melt (midazolam, ketamine and ondansetron) provides reliable dosing for conscious sedation in a sublingual lozenge.

ImprimisRx TotalTears treats dry eyes and inflammation in a single formula

ImprimisRx Klarity Drops provides five formulations in an excipient base of glycerine and dextran. The vehicle for Klarity Drops can be provided in base form, or it can be enhanced by azithromycin 1%, cyclosporine 0.1%, or loteprednol etabonate 0.5%. Klarity-CL offers cyclosporine 0.1% with loteprednol etabonate 0.2% ophthalmic suspension PF in the glycerin and dextran base.

ImprimisRx SimpleDrops ships important ophthalmic medications direct to the patient

Keeping the cost of daily eye drops affordable enhances compliance. Billing patient payment for prescription ophthalmic medication to the doctor rather than to the insurance increases office revenue. ImprimisRx offers a win-win for optic industry practitioners and their patients with drop shipment to the doctor or to the patient for:

  • LAT (latanoprost)
  • DOR (dorzolamide)
  • BRIM-DOR (brimonidine and dorzolamide)
  • TIM-LAT (timolol and latanoprost)
  • TIM-BRIM-DOR (timolol, brimonidine and dorzolamide)
  • TIM-DOR-LAT (timolol, dorzolamide and latanoprost)
  • TIM-BRIM-DOR-LAT (timolol, brimonidine, dorzolamide and latanoprost)

All ImprimisRx SimpleDrops products are preservative-free.

ImprimisRx provides essential medications for office exam

The ImprimisRx product line includes high-quality, affordable formulations of:

  • Atropine
  • Epinastine HCl – Brimonidine PF
  • Prednisolone Acetate PF
  • Mydriatic 2 (tropicamide and phenylephrine)* Multi-Dose 5 mL
  • Mydriatic 2 (tropicamide and phenylephrine)* Single-Use 5 mL
  • Mydriatic 3 (tropicamide, cyclopentolate and phenylephrine)
  • Mydriatic 4 (tropicamide, proparacaine, phenylephrine and ketorolac)

ImprimisRx provides the injectables ophthalmologists need for everyday practice

ImprimisRx offers important injected medications at reasonable cost:

  • Dex-Moxi (dexamethasone and moxifloxacin hydrochloride)
  • Dex-Moxi-Ketor (dexamethasone, moxifloxacin hydrochloride and ketorolac)
  • Lidocaine hydrochloride/Epinephrine in BSS
  • Moxifloxacin
  • Phenylephrine hydrochloride/Lidocaine hydrochloride

Other products by ImprimisRx are on the forward edge of innovation in ophthalmic solutions. in 2019, ImprimisRx Dropless antibiotic and steroid intravitreal injectable was featured in the authoritative Journal of Cataract and Refractive Surgery. The clinical trial found that Dropless may be a safe option for treating eyes with glaucoma having had cataract surgery with insertion of a trabecular microbypass stent.

In 2021, a multiple-center retrospective study demonstrated a statistically significant reduction in signs and symptoms of dry eyes after application of the ImprimisRx proprietary formula Klarity-C (chondroitin sulfate with cyclosporine 0.1% ophthalmic emulsion PF). The study reported in Clinical Ophthalmology found that the percentage of patients with severe dry eye disease dropped for 62 percent to 20 percent during the three months of the trial, with 34 percent achieving normal OSDI range. Corneal staining was 0 for 50 percent of patients.

ImprimisRx provides over 40 products to thousands of practitioners in all 50 states. ImprimisRx products require no prior authorizations with insurance companies and no manufacturer coupons or rebate forms. Every ImprimisRx product is manufactured in a 503B FDA-registered and inspected outsourcing facility and is supported by the positive experiences of thousands of patients across the United States.